These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2408588)

  • 1. Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma.
    Keller J; Kaltenecker A; Schricker KT; Neidhardt B; Hornstein OP
    Arch Dermatol Res; 1985; 277(4):323-5. PubMed ID: 2408588
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet responses observed during and after infusions of the prostacyclin analog ZK 36 374.
    Yardumian DA; Mackie IJ; Bull H; Machin SJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():359-62. PubMed ID: 2408446
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet sensitivity to a prostacyclin analogue in systemic sclerosis.
    Belch JJ; O'Dowd A; Forbes CD; Sturrock RD
    Br J Rheumatol; 1985 Nov; 24(4):346-50. PubMed ID: 2415199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
    Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation.
    Wadenvik H; Kutti J
    Acta Haematol; 1985; 73(4):224-7. PubMed ID: 2414956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of iloprost, a stable prostacyclin analog, on exercise capacity and platelet aggregation in stable angina pectoris.
    Bugiardini R; Galvani M; Ferrini D; Gridelli C; Mari L; Puddu P; Lenzi S
    Am J Cardiol; 1986 Sep; 58(6):453-9. PubMed ID: 2428231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function studies during and after infusions of ZK 36374, a stable prostacyclin analogue, to healthy volunteers.
    Yardumian DA; Mackie IJ; Brennan EC; Bull H; Machin SJ
    Haemostasis; 1986; 16(1):20-6. PubMed ID: 2422095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet sensitivity in vitro to the prostacyclin analogue iloprost in diabetic patients.
    Vicari AM; Macagni A; Pozza G
    Horm Metab Res; 1989 Nov; 21(11):616-8. PubMed ID: 2480323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Raynaud's phenomenon in scleroderma with a new stable prostacyclin derivative].
    Keller J; Kaltenecker A; Schricker KT; Krais T; Schönberger A; Gevatter M; Hornstein OP
    Dtsch Med Wochenschr; 1984 Sep; 109(38):1433-8. PubMed ID: 6383760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of iloprost on in vivo and in vitro platelet function in patients with peripheral vascular disease (PVD).
    Fitscha P; Tiso B; Krais T; Sinzinger H
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():450-4. PubMed ID: 2444079
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
    Pedvis LG; Wong T; Frojmovic MM
    Thromb Haemost; 1988 Apr; 59(2):323-8. PubMed ID: 2455359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation.
    Lidbury PS; Antunes E; de Nucci G; Vane JR
    Br J Pharmacol; 1989 Dec; 98(4):1275-80. PubMed ID: 2482103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central haemodynamic and antiplatelet effects of iloprost--a new prostacyclin analogue--in acute myocardial infarction in man.
    Swedberg K; Held P; Wadenvik H; Kutti J
    Eur Heart J; 1987 Apr; 8(4):362-8. PubMed ID: 2440682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotension in response to iloprost, a prostacyclin analogue.
    Upward JW; Strong HA; George CF; Ogilive BC; Challenor V; Conway N
    Br J Clin Pharmacol; 1986 Feb; 21(2):241-3. PubMed ID: 2420348
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs.
    Mackie IJ; Jones R; Machin SJ
    J Clin Pathol; 1984 Aug; 37(8):874-8. PubMed ID: 6206096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of ZK-96,480: a chemically and metabolically stable potent prostacyclin analogue.
    Skuballa W; Vorbrüggen H
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():271-3. PubMed ID: 2418656
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiplatelet effects of intravenous iloprost in patients with peripheral arterial obliterative disease. A placebo-controlled dose-response study.
    Darius H; Hossmann V; Schrör K
    Klin Wochenschr; 1986 Jun; 64(12):545-51. PubMed ID: 2426514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374).
    Kappa JR; Cottrell ED; Berkowitz HD; Fisher CA; Sobel M; Ellison N; Addonizio VP
    J Vasc Surg; 1987 May; 5(5):693-701. PubMed ID: 2437338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs.
    Hermán F; Hadházy P; Magyar K
    Arch Int Pharmacodyn Ther; 1989; 300():281-91. PubMed ID: 2482710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.